# Carl P. Griffin, M.D. – FDA Inspection, Nov 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/carl-p-griffin-md/725d056c-c599-4872-a646-fa9dd38f7672
Source feed: FDA_Inspections

> FDA inspection 1224307 of Carl P. Griffin, M.D., November 17, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224307
- Company Name: Carl P. Griffin, M.D.
- Inspection Date: 2023-11-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1149497 - 2021-08-05
- FDA Inspection 1079217 - 2019-02-01
- FDA Inspection 674866 - 2010-07-12
- [FDA Inspection 550865 - 2008-10-24](https://www.keypedia.com/records/fda_inspections/carl-p-griffin-md/f19dfce0-8120-4949-bc2c-18481aec99cb)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)
- [Issuing Officer](https://www.keypedia.com/people/terri-e-gibson/f1a80f95-a5c4-4cae-9a4b-e23f367770bb)

Company: https://www.keypedia.com/companies/carl-p-griffin-md/5b14aec8-5b8b-4da2-ad58-8a1980a45cc9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
